Search results for "COVID-19"


 
Results 131 - 140 of about 464 for "COVID-19".
Sort by: Relevance | Newest | Oldest

Latest updates on ACP's priorities, initiatives

ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://immattersacp.org/archives/2022/07/latest-updates-on-acps-priorities-initiatives.htm
1 Jul 2022

Belonging can boost well-being for physicians

A conversation between two experts at an Internal Medicine Meeting plenary session offers five ways to boost physicians' well-being.
https://immattersacp.org/archives/2022/07/belonging-can-boost-well-being-for-physicians.htm
1 Jul 2022

ACP convenes, in person and virtually, for Internal Medicine Meeting 2022

This month's issue considers coverage of Internal Medicine Meeting 2022, Leadership Day in Washington, D.C., and ACP's ninth COVID-19 forum.
https://immattersacp.org/archives/2022/07/acp-convenes-in-person-and-virtually-for-internal-medicine-meeting-2022.htm
1 Jul 2022

Oral medications for COVID-19 underused among socially vulnerable, CDC study finds

By late May, the rate of prescriptions for molnupiravir and nirmatrelvir/ritonavir was twice as high in the highest-income U.S. ZIP codes as in the lowest, research showed. A CDC webinar on June 28 will discuss efforts to equitably distribute these treatments.
https://immattersacp.org/weekly/archives/2022/06/28/2.htm
28 Jun 2022

ACP congratulates recent AMA election winners

Sandra A. Fryhofer, MD, MACP, was recently re-elected to the American Medical Association (AMA) Board of Trustees, and Suja Mathew, MD, FACP, was elected to the AMA Council on Medical Education.
https://immattersacp.org/weekly/archives/2022/06/28/5.htm
28 Jun 2022

Nirmatrelvir/ritonavir rarely leads to rebound, doesn't help average-risk patients, studies find

A retrospective analysis found that symptom rebound occurred in less than 1% of high-risk COVID-19 patients treated with nirmatrelvir/ritonavir, while the manufacturer reported that the drug didn't show significant benefit in average-risk patients.
https://immattersacp.org/weekly/archives/2022/06/21/2.htm
21 Jun 2022

Post-COVID-19 clinic director offers tips on lingering symptoms

The first step to treating patients with postacute sequelae of SARS-CoV-2 (PASC) is simple, one expert said: Believe them.
https://immattersacp.org/archives/2022/06/post-covid-19-clinic-director-offers-tips-on-lingering-symptoms.htm
1 Jun 2022

FDA considers new approach to safe disposal of opioids

This column reviews details on recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2022/06/fda-considers-new-approach-to-safe-disposal-of-opioids.htm
1 Jun 2022

Better care for patients with disability

Physicians report lacking knowledge about their legal responsibilities under the Americans with Disabilities Act (ADA) and may not be confident about their ability to provide the same quality of care to patients with disability as they do to those without it.
https://immattersacp.org/archives/2022/06/better-care-for-patients-with-disability.htm
1 Jun 2022

Making smoking cessation less of a struggle

This month's issue considers smoking cessation, helping patients with disabilities, and conference coverage from the Society of Hospital Medicine's annual meeting.
https://immattersacp.org/archives/2022/06/making-smoking-cessation-less-of-a-struggle.htm
1 Jun 2022

Result Page: Prev   9   10   11   12   13   14   15   16   17   18   Next